loadpatents
name:-0.034175872802734
name:-0.018045902252197
name:-0.0036559104919434
Connolly; Daniel T. Patent Filings

Connolly; Daniel T.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Connolly; Daniel T..The latest application filed is for "methods for determining probability of an adverse or favorable reaction to a niacin receptor agonist".

Company Profile
0.10.17
  • Connolly; Daniel T. - San Diego CA
  • Connolly; Daniel T. - Solana Beach CA
  • Connolly; Daniel T. - Ballwin MO
  • Connolly; Daniel T. - Carlsbad CA
  • Connolly, Daniel T. - Manchester MO
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Human G protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders
Grant 8,017,313 - Adams , et al. September 13, 2
2011-09-13
Human G protein-coupled receptors for metabolic-related disorders
Grant 7,829,298 - Unett , et al. November 9, 2
2010-11-09
Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
Grant 7,611,832 - Adams , et al. November 3, 2
2009-11-03
Methods for Determining Probability of an Adverse or Favorable Reaction to a Niacin Receptor Agonist
App 20090117559 - Liaw; Chen W. ;   et al.
2009-05-07
Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Hyperglycemia and Related Disorders
App 20080306114 - Qiu; Jun ;   et al.
2008-12-11
Methods and Compositions for the Treatment of Lipid-Associated Disorders
App 20080161422 - Kanemitsu-Parks; Martha ;   et al.
2008-07-03
Compositions For Treating Flushing And Lipid-Associated Disorders Comprising Niacin Receptor Partial Agonists
App 20080139628 - Behan; Dominic P. ;   et al.
2008-06-12
Human g protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders
App 20070231792 - Adams; John W. ;   et al.
2007-10-04
Human G protein-coupled receptor and modulators thereof for the treatment of cardiovascualr disorders
App 20070232519 - Adams; John W. ;   et al.
2007-10-04
Human G protein-coupled receptor and modulators thereof for the treatment of hyperglycemia and related disorders
App 20070231263 - Qiu; Jun ;   et al.
2007-10-04
Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
App 20070224127 - Adams; John W. ;   et al.
2007-09-27
Combinations of Cholesterol Ester Transfer Protein Inhibitors and HMG COA Reductase Inhibitors for Cardiovascular Indications
App 20070203246 - Keller; Bradley T. ;   et al.
2007-08-30
Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
App 20070072861 - Roniker; Barbara ;   et al.
2007-03-29
Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
App 20050238579 - Adams, John W. ;   et al.
2005-10-27
Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders
Grant 6,902,902 - Unett , et al. June 7, 2
2005-06-07
Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity
App 20040220231 - Lee, Len F. ;   et al.
2004-11-04
Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity
Grant 6,794,396 - Lee , et al. September 21, 2
2004-09-21
Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity
App 20040038939 - Lee, Len F. ;   et al.
2004-02-26
Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
App 20030203892 - Keller, Bradley T. ;   et al.
2003-10-30
Combinations of cholesteryl ester transfer protein inhibitors and HMG CoA reductase inhibitors for cardiovascular indications
App 20030166712 - Keller, Bradley T. ;   et al.
2003-09-04
Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity
Grant 6,605,624 - Lee , et al. August 12, 2
2003-08-12
Combinations of lleal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indications
App 20030125316 - Keller, Bradley T. ;   et al.
2003-07-03
Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
Grant 6,458,851 - Keller , et al. October 1, 2
2002-10-01
Combination therapy in the prevention of cardiovascular disorders
App 20020035156 - Roniker, Barbara ;   et al.
2002-03-21
DNA sequences encoding human vascular permeability factor having 189 amino acids
Grant 5,240,848 - Keck , et al. August 31, 1
1993-08-31
Antibodies to VPF
Grant 5,036,003 - Olander , et al. July 30, 1
1991-07-30
Method of determining the number of cells in cell culture
Grant 4,933,278 - Connolly June 12, 1
1990-06-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed